NCT01100151View on ClinicalTrials.gov

ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Opioid-induced Constipation
Interventions
DRUG

RDC-1036 (ALKS 37)

Capsules for oral administration

DRUG

Placebo

Capsules for oral administration

Trial Locations (11)

27103

Alkermes Investigational Site, Winston-Salem

32168

Alkermes Investigative Site, New Smyrna Beach

32734

Alkermes Investigational Site, DeLand

35660

Alkermes Investigational Site, Sheffield

45432

Alkermes Investigational Site, Dayton

70114

Alkermes Investigational Site, New Orleans

83704

Alkermes Investigational Site, Boise

84106

Alkermes Investigational Site, Salt Lake City

91105

Alkermes Investigational Site, Pasadena

92801

Alkermes Investigational Site, Anaheim

94598

Alkermes Investigational Site, Walnut Creek

Sponsors

Lead Sponsor

Alkermes, Inc.
All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY